Regeneron Pharmaceuticals...

NASDAQ: REGN · Real-Time Price · USD
520.94
-0.06 (-0.01%)
At close: Jun 27, 2025, 3:59 PM
521.01
0.01%
After-hours: Jun 27, 2025, 05:57 PM EDT

Regeneron Pharmaceuticals Revenue

Regeneron Pharmaceuticals reported an annual revenue of $14.2B, reflecting a 8.27% growth. For the quarter ending March 31, 2025, Regeneron Pharmaceuticals generated $3.03B in revenue.
Revenue (ttm)
$14.2B
Revenue Growth
8.27%
Price / Sales Ratio
5.41
Revenue / Employee
$936.93K
Employees
15,158
Market Cap
55.3B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.